Early Intervention With Acalabrutinib in Patients With High Risk CLL

Stopped Company supplying drug/funding ceased support.

Conditions

• Chronic Lymphocytic Leukemia
• CLL/SLL

Interventions

• DRUG: Acalabrutinib

Sponsor

Weill Medical College of Cornell University

Collaborators

• [object Object]